| Patent Number |
Title Of Patent |
Date Issued |
| 5747069 |
Percutaneously absorbable preparation |
May 5, 1998 |
| A percutaneously absorbable preparation containing a drug and a percutaneous absorption accelerator comprising a monoglyceride and a fatty acid. |
| 5683716 |
Encapsulated medicine |
November 4, 1997 |
| This invention relates to an encapsulated pharmaceutical dosage form comprising a practically insoluble compound or salt and an intracapsular fluid, and/or a surfactant and/or cellulose derivative. It provides for increased oral absorption as compared with the conventional system bec |
| 5045553 |
Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption pro |
September 3, 1991 |
| The present invention relates to a pharmaceutical composition for percutaneous drug absorption which comprises 5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and ethanol and/or an unsaturated higher fatty acid and to a composition of ma |
| 4916138 |
Solid dispersion composition of FR-900506 substance |
April 10, 1990 |
| This invention relates to a solid dispersion composition comprising FR-900506 substance and water-soluble hydroxypropyl methylcellulose which is capable of dispersing the FR-900506 substance, the FR-900506 substance and hydroxypropyl methylcellulose being in the ratio of 1:0:1 to 1:20 by |
| 4749574 |
Sustained-release transdermal delivery preparations |
June 7, 1988 |
| The invention relates to a sustained-release transdermal delivery preparation which comprises a slow-release microcapsule containing 2-nitroxymethyl-6-chloropyridine or its occlusion compound with .beta.-cyclodextrin and a skin-compatible base. |
